These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31539535)

  • 21. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.
    Hu P; Kinyamu HK; Wang L; Martin J; Archer TK; Teng C
    J Biol Chem; 2008 Mar; 283(11):6752-63. PubMed ID: 18174157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model.
    Cohen DJ; Patel V; Verma A; Boyan BD; Schwartz Z
    Steroids; 2019 Feb; 142():28-33. PubMed ID: 29133279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.
    Tanida T; Matsuda KI; Yamada S; Hashimoto T; Kawata M
    J Biol Chem; 2015 May; 290(19):12332-45. PubMed ID: 25805499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
    Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
    Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
    Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
    Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
    Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
    Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
    J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptors in breast carcinogenesis and endocrine therapy.
    Huang B; Warner M; Gustafsson JÅ
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():240-4. PubMed ID: 25433206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
    Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
    Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.
    Miah S; Bagu E; Goel R; Ogunbolude Y; Dai C; Ward A; Vizeacoumar FS; Davies G; Vizeacoumar FJ; Anderson D; Lukong KE
    BMC Cancer; 2019 Jan; 19(1):78. PubMed ID: 30651078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen metabolites and breast cancer.
    Santen RJ; Yue W; Wang JP
    Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
    Kerdivel G; Boudot A; Habauzit D; Percevault F; Demay F; Pakdel F; Flouriot G
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):34-44. PubMed ID: 24721635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a multi-target compound for estrogen receptor-positive (ER
    Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
    Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memo interacts with c-Src to control Estrogen Receptor alpha sub-cellular localization.
    Frei A; MacDonald G; Lund I; Gustafsson JÅ; Hynes NE; Nalvarte I
    Oncotarget; 2016 Aug; 7(35):56170-56182. PubMed ID: 27472465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Radojicic J; Leclercq G; Castanas E; Stathopoulos EN
    Steroids; 2012 Aug; 77(10):928-34. PubMed ID: 22198466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression signature of estrogen receptor alpha status in breast cancer.
    Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
    BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.